<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23244685</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>04</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1479-7364</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>6</Volume>
                    <PubDate>
                        <Year>2012</Year>
                        <Month>Sep</Month>
                        <Day>04</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Human genomics</Title>
                <ISOAbbreviation>Hum Genomics</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.</ArticleTitle>
            <Pagination>
                <MedlinePgn>18</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/1479-7364-6-18</ELocationID>
            <Abstract>
                <AbstractText>Neurofibromatosis type-1 (NF1), resulting from NF1 gene loss of function, is characterized by an increased risk of developing benign and malignant peripheral nerve sheath tumors (MPNSTs). Whereas the cellular heterogeneity of NF1-associated tumors has been well studied, the molecular heterogeneity of MPNSTs is still poorly understood. Mutational heterogeneity within these malignant tumors greatly complicates the study of the underlying mechanisms of tumorigenesis. We have explored this molecular heterogeneity by performing loss of heterozygosity (LOH) analysis of the NF1, TP53, RB1, PTEN, and CDKN2A genes on sections of 10 MPNSTs derived from 10 unrelated NF1 patients. LOH data for the TP53 gene was found to correlate with the results of p53 immunohistochemical analysis in the same tumor sections. Further, approximately 70% of MPNSTs were found to display intra-tumoral molecular heterogeneity as evidenced by differences in the level of LOH between different sections of the same tumor samples. This study constitutes the first systematic analysis of molecular heterogeneity within MPNSTs derived from NF1 patients. Appreciation of the existence of molecular heterogeneity in NF1-associated tumors is important not only for optimizing somatic mutation detection, but also for understanding the mechanisms of NF1 tumorigenesis, a prerequisite for the development of specifically targeted cancer therapeutics.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Thomas</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Genetics, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mautner</LastName>
                    <ForeName>Victor-Felix</ForeName>
                    <Initials>VF</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cooper</LastName>
                    <ForeName>David N</ForeName>
                    <Initials>DN</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Upadhyaya</LastName>
                    <ForeName>Meena</ForeName>
                    <Initials>M</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <Agency>Cancer Research UK</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2012</Year>
                <Month>09</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Hum Genomics</MedlineTA>
            <NlmUniqueID>101202210</NlmUniqueID>
            <ISSNLinking>1473-9542</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016160">Retinoblastoma Protein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C495901">TP53 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016159">Tumor Suppressor Protein p53</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.1.3.67</RegistryNumber>
                <NameOfSubstance UI="D051059">PTEN Phosphohydrolase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.1.3.67</RegistryNumber>
                <NameOfSubstance UI="C494929">PTEN protein, human</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D016514" MajorTopicYN="N">Genes, Neurofibromatosis 1</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019942" MajorTopicYN="N">Genes, p16</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016158" MajorTopicYN="N">Genes, p53</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056426" MajorTopicYN="N">Genetic Loci</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019656" MajorTopicYN="Y">Loss of Heterozygosity</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018317" MajorTopicYN="N">Nerve Sheath Neoplasms</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009456" MajorTopicYN="N">Neurofibromatosis 1</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051059" MajorTopicYN="N">PTEN Phosphohydrolase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016160" MajorTopicYN="N">Retinoblastoma Protein</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016159" MajorTopicYN="N">Tumor Suppressor Protein p53</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2012</Year>
                <Month>06</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2012</Year>
                <Month>07</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2012</Year>
                <Month>12</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2012</Year>
                <Month>12</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>4</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23244685</ArticleId>
            <ArticleId IdType="pii">1479-7364-6-18</ArticleId>
            <ArticleId IdType="doi">10.1186/1479-7364-6-18</ArticleId>
            <ArticleId IdType="pmc">PMC3500234</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Expert Rev Mol Med. 2009;11:e30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19835664</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Pathol. 1999 Dec;155(6):1879-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10595918</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2010 Oct 28;467(7319):1109-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20981101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19479-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19846776</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2008 Feb 15;14(4):1015-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18281533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mutat. 2011 Jan;32(1):78-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21031597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genet Med. 2010 Jan;12(1):1-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20027112</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Biosci (Landmark Ed). 2011;16:937-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21196210</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2001 Feb 1;61(3):1154-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11221846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virchows Arch. 2002 Jun;440(6):610-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12070601</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mutat. 2004 Feb;23(2):134-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14722917</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Oncol. 2001 Aug;19(2):331-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11445847</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Hum Genet. 2012 Apr;20(4):411-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22108604</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Genet. 1995 Oct;11(2):210-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7550353</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2002 Nov;8(11):1323-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12389040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 1991 Sep 11;19(17):4796</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1716362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pract Neurol. 2010 Apr;10(2):82-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20308235</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2006 Mar 1;66(5):2584-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16510576</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurogenetics. 2010 Oct;11(4):391-400</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20358387</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2011 Jan 20;469(7330):314-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21248838</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Neurol. 2004 Apr;17(2):101-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15021234</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Syst Biol. 2010 May 11;6:369</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20461076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ACS Nano. 2010 May 25;4(5):2755-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20377268</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2007 Jul 12;26(32):4609-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17297459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 2011 Jan 4;104(1):120-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21139586</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1999 Dec 10;286(5447):2172-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10591652</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mutat. 2008 Aug;29(8):E103-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18484666</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2001 Feb 23;104(4):593-604</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11239415</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Hum Genet. 1989 Oct;45(4):547-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2577468</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2000 Feb 3;403(6769):503-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10676951</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2010 Dec 23;468(7327):1095-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21150899</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2005 Jan 14;11(2):285-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15633233</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Med Diagn. 2010 Jul;4(4):307-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23496147</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Dev Pathol. 1999 Jul-Aug;2(4):377-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10347283</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lab Invest. 2000 May;80(5):709-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10830781</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2002 Nov 1;62(21):6011-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12414620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 2005 Dec 21;97(24):1808-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16368942</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Pathol. 1999 Dec;155(6):1855-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10595915</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2010 Mar 20;28(9):1573-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20159821</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1994 Jan 1;73(1):118-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8275415</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2011 May 19;30(20):2333-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21242963</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Cancer. 2007 Oct;7(10):791-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17851544</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurosurgery. 2006 Jan;58(1):1-16; discussion 1-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16385324</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diagn Mol Pathol. 1996 Sep;5(3):214-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8866236</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Pathol. 2000 Feb;31(2):233-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10685639</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
